Wird geladen...

Preclinical and Clinical Pharmacology of Cyamemazine: Anxiolytic Effects and Prevention of Alcohol and Benzodiazepine Withdrawal Syndrome

Several studies have suggested that the antipsychotic compound, cyamemazine, possesses anxiolytic properties in humans. The original pharmacological profile of cyamemazine (D(2), 5‐HT(2A), 5‐HT(2C), and 5‐HT(3) receptor antagonist), which was established by binding, microdialysis and behavioral stud...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:CNS Drug Rev
Hauptverfasser: Bourin, Michel, Dailly, Eric, Hascöet, Martine
Format: Artigo
Sprache:Inglês
Veröffentlicht: Blackwell Publishing Ltd 2006
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6741725/
https://ncbi.nlm.nih.gov/pubmed/15492772
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1527-3458.2004.tb00023.x
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!